Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)

CNY 4.77

(0.0%)

Market Cap (In CNY)

11.92 Billion

Revenue (In CNY)

6.73 Billion

Net Income (In CNY)

591.57 Million

Avg. Volume

25.28 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.91-5.54
PE
-
EPS
-
Beta Value
0.397
ISIN
CNE000001H86
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Guoliang Luo
Employee Count
-
Website
https://www.conbagroup.com
Ipo Date
2004-04-12
Details
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of traditional Chinese medicines and botanical products in China. It offers chemical medicines, Chinese patent medicines, eye health products, nutritional supplements, health supplies, healthy daily necessities and food products, and other personal care products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.